G G Steger Selected Research

G G Steger Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2000
9	Neoplasms (Cancer) 02/2014 - 04/2000
6	Colonic Neoplasms (Colon Cancer) 01/2011 - 06/2001
3	Neoplasm Metastasis (Metastasis) 03/2003 - 03/2000
2	Triple Negative Breast Neoplasms 04/2017 - 01/2012
2	Brain Neoplasms (Brain Tumor) 01/2012 - 01/2012
2	Hemorrhage 02/2006 - 03/2001
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2000 - 03/2000
1	Pathologic Complete Response 02/2014
1	Male Breast Neoplasms (Male Breast Cancer) 06/2013
1	Overweight 04/2013
1	Disease Progression 11/2012
1	Adenocarcinoma 11/2012
1	Pulmonary Embolism 02/2006
1	Thrombosis (Thrombus) 02/2006
1	Mucositis 11/2001
1	Ulcer 11/2001
1	Stomatitis 11/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2001
1	Thrombocytopenia (Thrombopenia) 03/2001
1	Liver Neoplasms (Liver Cancer) 10/2000
1	Hypotension (Low Blood Pressure) 09/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2000
1	Carcinoma (Carcinomatosis) 09/2000
1	Capillary Leak Syndrome 09/2000
1	Inflammation (Inflammations) 09/2000
1	Ovarian Neoplasms (Ovarian Cancer) 07/2000
1	Microsatellite Instability 04/2000
1	Persistent Infection 02/2000
1	Hepatocellular Carcinoma (Hepatoma) 02/2000
1	Hepatitis 02/2000

Drug/Important Bio-Agent (IBA)

6	Fluorouracil (Carac)FDA LinkGeneric 01/2011 - 04/2000
4	Hormones (Hormone)IBA 12/2021 - 04/2013
4	Capecitabine (Xeloda)FDA Link 02/2014 - 12/2002
4	Docetaxel (Taxotere)FDA Link 02/2014 - 03/2000
4	AnthracyclinesIBA 11/2001 - 03/2000
3	Trastuzumab (Herceptin)FDA Link 02/2014 - 09/2003
3	Gemcitabine FDA Link 03/2001 - 09/2000
3	Interleukin-2 (IL2)IBA 10/2000 - 09/2000
2	Bevacizumab (Avastin)FDA Link 04/2017 - 11/2012
2	Aromatase InhibitorsIBA 06/2013 - 04/2013
2	Fulvestrant (Faslodex)FDA Link 06/2010 - 11/2005
2	CytokinesIBA 09/2000 - 09/2000
2	Cisplatin (Platino)FDA LinkGeneric 09/2000 - 07/2000
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	abemaciclibIBA 12/2021
1	Epirubicin (Ellence)FDA LinkGeneric 02/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2013
1	Tamoxifen FDA LinkGeneric 04/2013
1	Aminoglutethimide (Cytadren)FDA Link 04/2013
1	Epidermal Growth Factor (EGF)IBA 11/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2012
1	Immunoglobulin G (IgG)IBA 09/2012
1	Epithelial Cell Adhesion MoleculeIBA 09/2012
1	adecatumumabIBA 09/2012
1	Phenobarbital (Luminal)FDA Link 01/2012
1	Lapatinib (GW572016)FDA Link 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2011
1	human ERBB2 proteinIBA 06/2010
1	Leucovorin (Folinic Acid)FDA Link 10/2007
1	AnticoagulantsIBA 02/2006
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2006
1	Dalteparin (Dalteparin Sodium)FDA Link 02/2006
1	ImmunosorbentsIBA 09/2003
1	EnzymesIBA 09/2003
1	5'-deoxy-5-fluorocytidineIBA 03/2003
1	doxifluridineIBA 03/2003
1	Povidone-Iodine (Betadine)FDA LinkGeneric 11/2001
1	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2001
1	molgramostimIBA 11/2001
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2001
1	Messenger RNA (mRNA)IBA 06/2001
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2000
1	NitratesIBA 09/2000
1	Interferon-gamma (Interferon, gamma)IBA 09/2000
1	Glutathione (Reduced Glutathione)IBA 07/2000
1	Methotrexate (Mexate)FDA LinkGeneric 04/2000
1	Pharmaceutical PreparationsIBA 04/2000
1	Proteins (Proteins, Gene)FDA Link 04/2000
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2000
1	Immunologic Factors (Immunomodulators)IBA 03/2000
1	Interferon-alpha2bIBA 02/2000
1	Interferon-alpha (Interferon Alfa)IBA 02/2000
1	AntibodiesIBA 02/2000

Therapy/Procedure

6	Therapeutics 12/2021 - 03/2000
6	Drug Therapy (Chemotherapy) 02/2006 - 03/2000
3	Adjuvant Chemotherapy 01/2019 - 10/2007
2	Combination Drug Therapy (Combination Chemotherapy) 12/2000 - 09/2000
1	Neoadjuvant Therapy 02/2014
1	Subcutaneous Injections 02/2006
1	Thrombolytic Therapy 02/2006
1	Catheters 02/2006
1	Central Venous Catheters 02/2006
1	Duration of Therapy 11/2001
1	Immunotherapy 09/2000